James Molloy

Stock Analyst at Alliance Global Partners

(0.40)
# 4,186
Out of 5,022 analysts
33
Total ratings
23.53%
Success rate
-41.16%
Average return

Stocks Rated by James Molloy

Soligenix
Jul 16, 2025
Maintains: Buy
Price Target: $10$6
Current: $1.63
Upside: +268.10%
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.42
Upside: +740.74%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.28
Upside: +2,902.47%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $21.81
Upside: +60.48%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.60
Upside: +2,382.21%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $1.87
Upside: +969.52%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $14.58
Upside: +3,260.77%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600$1,100
Current: $20.01
Upside: +5,397.25%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.59
Upside: +196.61%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.85
Upside: +251.12%
Maintains: Buy
Price Target: $9$14
Current: $0.87
Upside: +1,500.37%
Initiates: Buy
Price Target: $30
Current: $1.67
Upside: +1,696.41%
Initiates: Buy
Price Target: $7.5
Current: $1.24
Upside: +507.29%
Reiterates: Buy
Price Target: $20
Current: $5.35
Upside: +273.83%
Maintains: Buy
Price Target: $14$8
Current: $2.05
Upside: +290.24%
Maintains: Buy
Price Target: $10$7
Current: $6.88
Upside: +1.74%
Initiates: Buy
Price Target: $80
Current: $0.95
Upside: +8,364.71%
Initiates: Buy
Price Target: $16
Current: $0.59
Upside: +2,616.47%
Initiates: Buy
Price Target: $280
Current: $7.59
Upside: +3,589.06%
Initiates: Buy
Price Target: $196
Current: $5.10
Upside: +3,736.27%
Initiates: Buy
Price Target: $8,400
Current: $14.05
Upside: +59,686.48%
Initiates: Buy
Price Target: $150
Current: $2.27
Upside: +6,507.93%
Initiates: Buy
Price Target: $938
Current: $0.72
Upside: +129,424.73%
Initiates: Buy
Price Target: $25
Current: $3.16
Upside: +691.14%